Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Receives FDA Clearance For Its Cellvizio® Platform

March 3 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES RECEIVES FDA CLEARANCE AND CE
MARKING FOR
ITS NEXT-GENERATION CELLVIZIO® PLATFORM
    * MAUNA KEA TECHNOLOGIES SAS SAYS NEW CELLVIZIO® PLATFORM
INCLUDES
SIGNIFICANT IMPROVEMENTS AND WILL ENABLE MAJOR INNOVATIONS
    * MAUNA KEA TECHNOLOGIES SAS ANNOUNCED  THAT IT HAS OBTAINED
510(K) CLEARANCE (K193416) FROM THE U.S. FOOD AND DRUG
ADMINISTRATION (FDA) AND CE MARKING OF CELLVIZIO® ENDOMICROSCOPY
PLATFORM

Source text for Eikon:  ID:nBw9Y6p8sa 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Mauna Kea Technologies SA

See all news